Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-11-03
DOI
10.3389/fcell.2023.1320084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer
- (2023) Dino Bekric et al. Cancers
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis
- (2021) Eduardo A. Vega et al. ANNALS OF SURGICAL ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future
- (2021) Matthias Ocker et al. Cancers
- HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
- (2021) Christian Mayr et al. Cancers
- Epidemiology of Hepatocellular Carcinoma
- (2020) Katherine A. McGlynn et al. HEPATOLOGY
- Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
- (2019) Daniel Neureiter et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
- (2019) Florian Moik et al. Scientific Reports
- Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma
- (2018) N. T. E. Bird et al. BRITISH JOURNAL OF SURGERY
- Sorafenib: A Review in Hepatocellular Carcinoma
- (2017) Gillian M. Keating Targeted Oncology
- Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium
- (2016) Georgios Antonios Margonis et al. HPB
- Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
- (2015) Jiang Chen et al. CANCER LETTERS
- Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection
- (2015) Bas Groot Koerkamp et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- The role of polycomb repressive complexes in biliary tract cancer
- (2014) Christian Mayr et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma
- (2014) Michael N. Mavros et al. JAMA Surgery
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Management of Gallbladder Carcinoma
- (2010) A. X. Zhu et al. ONCOLOGIST
- Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma
- (2008) Armin Thelen et al. JOURNAL OF GASTROENTEROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation